
Join to View Full Profile
75 Francis StBoston, MA 02115
Phone+1 617-732-5500
Dr. Pabon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Maria Pabon is a cardiologist based in Boston, MA, who graduated from the National University of Colombia in 2013. She completed her internal medicine residency at the New York Presbyterian Hospital - Weill Cornell Medical Center and her cardiology fellowship at Brigham and Women's Hospital, Harvard Medical School. She has contributed to the field through several publications in reputable journals, including research on cardiovascular health, heart failure, and preeclampsia. Noteworthy publications include studies in the Journal of the American College of Cardiology, JAMA Cardiology, Circulation Research, the European Journal of Heart Failure, and the Annals of Noninvasive Electrocardiology.
Education & Training
- National University of ColombiaClass of 2013
Certifications & Licensure
- MA State Medical License 2020 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Finerenone Reduces New-Onset Atrial Fibrillation Across the Spectrum of Cardio-Kidney-Metabolic Syndrome: The FINE-HEART Pooled Analysis.Maria A Pabon, Gerasimos Filippatos, Brian L Claggett, Michael Zi Miao, Akshay S Desai
Journal of the American College of Cardiology. 2025-05-06 - 1 citationsGenetic Risk and First-Trimester Cardiovascular Health Predict Hypertensive Disorders of Pregnancy in Nulliparous Women.Vineetha Mathew, Raiyan R Khan, Amanda R Jowell, Qi Yan, Itsik Pe'er
Journal of the American College of Cardiology. 2025-04-15 - Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Randomized Clinical Trial.Akshay S Desai, Pardeep S Jhund, Muthiah Vaduganathan, Brian L Claggett, Jonathan W Cunningham
JAMA Cardiology. 2025-03-30
Press Mentions
- Bayer's Finerenone Reduces Risk of AFib, Atrial Flutter in All CKM Syndrome PatientsApril 29th, 2025
- ACC.25 Science Published Across JACC JournalsMarch 24th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: